Methotrexate treatment in 13 children with severe plaque psoriasis

Clinical and Experimental Dermatology

Volumn 34, Issue 3, 2009, Pages 295-298

  Collin, B ^a,b   Vani, A ^a   Ogboli, M ^a   Moss, C ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN; FOLIC ACID; METHOTREXATE;

ABDOMINAL PAIN; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILD; CLINICAL ARTICLE; COUGHING; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; LEG PAIN; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; MOUTH ULCER; NAUSEA; NONALCOHOLIC FATTY LIVER; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PSORIASIS VULGARIS; SCHOOL CHILD; SIDE EFFECT; SKIN BRUISING; TREATMENT DURATION; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION; VOMITING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; PSORIASIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 62449288767     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02907.x     Document Type: Article

References (10)

1. Burden AD. Management of psoriasis in childhood. Clin Exp Dermatol 1999 24 : 341 5.
2. Kennedy T, McCabe C, Struthers G et al. British Society for Rheumatology Standards, Guidelines and Audit Working Group (SGAWG) BSR guidelines on standards of care for persons with rheumatoid arthritis. Rheumatology (Oxford) 2005 44 : 553 6.
3. Kalla G, Goyal A. M. Juvenile generalised pustular psoriasis. Pediatr Dermatol 1996 13 : 45 6.
4. Dogra S, Handa S, Kanwar A. J, Methotrexate in severe childhood psoriasis. Pediatr Dermatol 2004 21 : 283 4.
5. Juanqin G, Zhiqiang C, Zijia H. Evaluation of the effectiveness of childhood generalised pustular psoriasis treatment in 30 cases. Pediatr Dermatol 1998 15 : 144 6.
6. Kumar B, Dhar S, Handa S, Kaur I. Methotrexate in childhood psoriasis. Pediatr Dermatol 1994 11 : 271 3.
7. Schwimmer JB, Deutsch R, Kahen T et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006 118 : 1388 93.
8. Rosenberg P, Urwitz H, Johannesson A et al. Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment. J Hepatol 2007 46 : 1111 18.
9. Macdonald A, Burden AD. Non invasive monitoring for methotrexate hepatotoxicity. Br J Dermatol 2005 152 : 405 8.
10. British Society for Rheumatology. Extract From British Society for Rheumatology DMARD Guidelines. 2006. http://www.bad.org.uk/healthcare/service/ bsr-dmard-guidelines-2006-methotrexate.pdf (accessed 3 April 2008).